SAG
ORGO icon

SageView Advisory Group’s Organogenesis Holdings ORGO Stock Holding History

SageView Advisory Group’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-188
Closed -$974 – 1852
2025
Q4 		$974 Buy
+188
New +$911 ﹤0.01% 2363

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

SageView Advisory Group's ORGO Position: Q1 2026 in Review

SageView Advisory Group sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 188 shares — an estimated $974 sold.

SageView Advisory Group first reported a position in ORGO in Q4 2025 and held it in 1 quarter. The position peaked at $974 in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • SageView Advisory Group reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
  • SageView Advisory Group sold 188 Organogenesis Holdings shares in Q1 2026, an estimated $974.
  • SageView Advisory Group first reported a position in Organogenesis Holdings in Q4 2025 and held it in 1 quarter.
  • SageView Advisory Group's Organogenesis Holdings position peaked at $974 in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.